Ramiro Sanchez
CIK 1830326 · Chief Medical Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
19
Lifetime Open-Market Net
-$1.57M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Director | — | $41.96 | — | $0 | 3 | 2026-06-10 |
| ANRO | Director | — | $27.42 | — | $0 | 3 | 2026-05-14 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Chief Medical Officer | 24,673 | $44.96 | $1.11M | -$1.57M | 7 | 2024-01-23 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Chief Medical Officer | — | $18.07 | — | $0 | 2 | 2021-02-05 |
Recent Filings · Page 2 of 2
19 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-21 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | +14,673 | -$420.5K | EDGAR |
| 2023-12-19 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$236.3K | EDGAR |
| 2023-12-15 | — | Notice (144) | −7,500 | -$310.4K | EDGAR |
| 2023-12-11 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$378.7K | EDGAR |
| 2023-12-07 | — | Notice (144) | −10,000 | -$413.7K | EDGAR |
| 2023-02-08 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-11 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-05 | Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-30 | Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.